Abstract is: Cyanocobalamin is a form of vitamin B12 used to treat vitamin B12 deficiency except in the presence of cyanide toxicity. The deficiency may occur in pernicious anemia, following surgical removal of the stomach, with fish tapeworm, or due to bowel cancer. It is less preferred than hydroxocobalamin for treating vitamin B12 deficiency. It is used by mouth, by injection into a muscle, or as a nasal spray. Cyanocobalamin is generally well tolerated. Minor side effects may include diarrhea and itchiness. Serious side effects may include anaphylaxis, low blood potassium, and heart failure. Use is not recommended in those who are allergic to cobalt or have Leber's disease. Vitamin B12 is an essential nutrient meaning that it cannot be made by the body but is required for life. Cyanocobalamin was first manufactured in the 1940s. It is available as a generic medication and over the counter. In 2020, it was the 105th most commonly prescribed medication in the United States, with more than 6 million prescriptions.
| type of chemical entity | Q113145171 |
| vitamin B12 | Q187706 |
| cobalamin | Q3329800 |
| P3780 | active ingredient in | Nascobal | Q47521870 |
| P4250 | defined daily dose | 1 | |
| P1889 | different from | vitamin B12 | Q187706 |
| P527 | has part(s) | hydrogen | Q556 |
| carbon | Q623 | ||
| nitrogen | Q627 | ||
| oxygen | Q629 | ||
| phosphorus | Q674 | ||
| cobalt | Q740 | ||
| P366 | has use | medication | Q12140 |
| P2067 | mass | 1354.567 | |
| P2175 | medical condition treated | multiple sclerosis | Q8277 |
| pernicious anemia | Q1346016 | ||
| alcoholic neuropathy | Q4062508 | ||
| diabetic polyneuropathy | Q4160985 | ||
| P361 | part of | cyanocobalamin reductase (cyanide-eliminating) activity | Q22318031 |
| P4952 | safety classification and labelling | NFPA 704: Standard System for the Identification of the Hazards of Materials for Emergency Response | Q51139288 |
| P2868 | subject has role | vitamin B | Q183206 |
| Q36088916 | 4-Chloro-α-cyanocinnamic acid is an efficient soft matrix for cyanocobalamin detection in foodstuffs by matrix-assisted laser desorption/ionization mass spectrometry (MALDI MS). |
| Q58934722 | A Cyanocobalamin–Protein Complex from Sow's Milk and Desiccated Pig Stomach |
| Q58011165 | A controlled trial of cyanocobalamin (Vitamin B12) in the treatment of winter seasonal affective disorder |
| Q41648852 | A derivative of R-type cyanocobalamin binding proteins in the human intestine. A candidate antibacterial molecule |
| Q42832184 | A dodecylamine derivative of cyanocobalamin potently inhibits the activities of cobalamin-dependent methylmalonyl-CoA mutase and methionine synthase of Caenorhabditis elegans. |
| Q38970525 | ABSORPTION OF CO58 LABELED CYANOCOBALAMIN IN PROTEIN DEFICIENCY. AN EXPERIMENTAL STUDY IN THE RHESUS MONKEY |
| Q42125624 | Absorption of heparin and cyanocobalamin from the rat lung |
| Q46193162 | Absorption of vitamin B12 by the guinea-pig. II. The subcellular localization of cyano-, methyl- and adenosyl-cobalamins and the effect of fluoroacetate on cyanocobalamin absorption |
| Q51682655 | Absorption of vitamin B12 in the guinea-pig. 3. The forms of vitamin B12 in ileal mucosa and portal plasma in the fasting state and during absorption of cyanocobalamin. |
| Q41158922 | Acute psychosis: a presentation of cyanocobalamin deficiency megaloblastic anemia |
| Q45005665 | Adverse reactions to vitamin B12 injections due to benzyl alcohol sensitivity: successful treatment with intranasal cyanocobalamin. |
| Q41223250 | An assessment of serum 57Co cyanocobalamin as an index of vitamin B12 absorption |
| Q36621978 | An assessment of serum 57Co cyanocobalamin as an index of vitamin B12 absorption1 |
| Q41501012 | An evaluation of simultaneously administered free and intrinsic factor bound radioactive cyanocobalamin in the diagnosis of pernicious anaemia in the elderly |
| Q55449464 | Anaphylactic Reaction to Cyanocobalamin: A Case Report. |
| Q43228422 | Anaphylactoid reaction to hydroxycobalamin with tolerance of cyanocobalamin. |
| Q45955967 | Anaphylaxis due to sulfite intolerance: a protective effect from cyanocobalamin. |
| Q43800881 | Antinociceptive properties of thiamine, pyridoxine and cyanocobalamin following repeated oral administration to mice |
| Q78664848 | Aphrodisiac effects of high doses of vitamine B12 |
| Q51836493 | Application of orthogonal functions to spectrophotometric analysis of the preservatives benzylalcohol, phenol and parabens in aqueous cyanocobalamin solutions. |
| Q54578589 | Assessment of vitamin B(12) absorption based on the accumulation of orally administered cyanocobalamin on transcobalamin. |
| Q26783632 | Associations between B Vitamins and Parkinson's Disease |
| Q45492177 | Atypical hemolytic uremic syndrome induced by CblC subtype of methylmalonic academia: A case report and literature review |
| Q34456976 | Biochemical and clinical response to hydroxocobalamin versus cyanocobalamin treatment in patients with methylmalonic acidemia and homocystinuria (cblC). |
| Q44743015 | Body retention of a depot preparation of cyanocobalamin compared with hydroxycobalamin |
| Q41459635 | Carbon-13 nuclear magnetic resonance studies of cyanocobalamin and several of its analogues |
| Q59000841 | Changes in the Blood of the Rat induced by the Monocarboxylic Acid of Cyanocobalamin obtained by Fermentation (anti-Vitamin B12) |
| Q43589995 | Changes in the uptake of 57Co-cyanocobalamin during dimethylsulphoxide-induced differentiation of HL60 cells to neutrophils |
| Q52048677 | Characteristics of non-cobalamin deficient patients who receive regular cyanocobalamin injections. |
| Q42240138 | Chloramphenicol optic neuritis. Apparent protective effects of very high daily doses of pyridoxine and cyanocobalamin |
| Q42171918 | Chromatographic study of photolysis of aqueous cyanocobalamin solution in presence of vitamins B and C. |
| Q58842981 | Combined use of ascorbic acid and cyanocobalamin in clearance of Trypanosoma cruzi |
| Q46520047 | Comment on Wang et al.: Thiamine, pyridoxine, cyanocobalamin and their combination inhibit thermal, but not mechanical hyperalgesia in rats with primary sensory neuron injury (Pain 2005;114:266-77). |
| Q41346145 | Common vitamin B complex agents and folic acid: Part I. Cyanocobalamin (vitamin B12) (kaybovite [parenteral]; berubigen; betalin-12; kaybovite-1000; rubramin-pc). |
| Q46696266 | Comparative effects of hydroxocobalamin and cyanocobalamin on plasma homocysteine concentrations in end-stage renal disease |
| Q47920009 | Comparative evaluation of the electrophysiological, functional and ultrastructural effects of alpha lipoic acid and cyanocobalamin administration in a rat model of sciatic nerve injury |
| Q54756598 | Comparative studies made of the intravital retention of hydroxy-cobalamin and cyanocobalamin in the normal individual |
| Q48116009 | Conformational Dynamics of Cyanocobalamin and Its Conjugates with Peptide Nucleic Acids. |
| Q33873457 | Cyanocobalamin (vitamin B-12) status in Seventh-day Adventist ministers in Australia |
| Q40261464 | Cyanocobalamin (vitamin B12) conjugates with enhanced solubility |
| Q44698860 | Cyanocobalamin Reference Standard (Control 891) of National Institute of Hygienic Sciences |
| Q42221195 | Cyanocobalamin absorption in the elderly: results for healthy subjects and for subjects with low serum cobalamin concentration |
| Q44172257 | Cyanocobalamin degradation |
| Q39525466 | Cyanocobalamin injections for patients without documented deficiency. Reasons for administration and patient responses to proposed discontinuation |
| Q52766140 | Cyanocobalamin solutions as potential dosimeters in low-dose food irradiations. |
| Q46203136 | Cyanocobalamin, vitamin B12, depresses glutamate release through inhibition of voltage-dependent Ca2+ influx in rat cerebrocortical nerve terminals (synaptosomes). |
| Q55458320 | Cyanocobalamin--a case for withdrawal. |
| Q55438563 | Cyanocobalamin--a case for withdrawal: discussion paper |
| Q41076230 | Defective leukocyte metabolism in human cobalamin deficiency: impaired propionate oxidation and serine biosynthesis reversible by cyanocobalamin therapy |
| Q46201423 | Derivative spectrophotometry in the visible region using absorbance versus log wavelength or wavenumber determination of cyanocobalamin in injection solutions. |
| Q52627645 | Desensitization to Cyanocobalamin: Rush Protocol. |
| Q50065735 | Determination of cyanocobalamin by isotope dilution LC-MS/MS. |
| Q42283961 | Determination of hydroxocobalamin and cyanocobalamin by derivative spectrophotometry in cyanide poisoning |
| Q37396276 | Diabetic retinopathy and cyanocobalamin (vitamin B12); a preliminary report |
| Q45232137 | Diffusion permeability of cyanocobalamin in human placenta |
| Q51226092 | Early biochemical and hematological response to intramuscular cyanocobalamin therapy in vitamin B(12)-deficient patients. |
| Q42921302 | Effect of ascorbic acid on the degradation of cyanocobalamin and hydroxocobalamin in aqueous solution: a kinetic study |
| Q43249579 | Effect of butaphosphane and cyanocobalamin on regeneration of muscle fibres in pigs. |
| Q51065393 | Effect of combined acetylmethionine, cyanocobalamin and α-lipoic acid on hepatic metabolism in high-yielding dairy cow. |
| Q42932200 | Effect of multiple intravenous injections of butaphosphan and cyanocobalamin on the metabolism of periparturient dairy cows |
| Q44332609 | Effect of nicotinamide on the photolysis of cyanocobalamin in aqueous solution |
| Q46232478 | Effect of reduction of disulfide bonds on uptake of intrinsic factor-cyanocobalamin complex by homogenates of guinea pig ileum |
| Q46523413 | Effect of various halide salts on the incompatibility of cyanocobalamin and ascorbic acid in aqueous solution |
| Q38953128 | Effects of a combination butaphosphan and cyanocobalamin product and insulin on ketosis resolution and milk production. |
| Q47936119 | Effects of butafosfan with or without cyanocobalamin on the metabolism of early lactating cows with subclinical ketosis |
| Q41774997 | Effects of chemical and physical enhancement techniques on transdermal delivery of cyanocobalamin (vitamin B12) in vitro |
| Q37661058 | Effects of oral crystalline cyanocobalamin 1000 μg/d in the treatment of pernicious anemia: An open-label, prospective study in Ten Patients. |
| Q41749386 | Effects of phenytoin sodium on doubling time, deoxyuridine suppression, 3H-methotrexate uptake and 57Co-cyanocobalamin uptake in HL60 cells. |
| Q50501916 | Efficacy of a 28-day oral cyanocobalamin supplementation on vitamin B status in Spanish institutionalized elderly. |
| Q47882993 | Electrospun formulations of acyclovir, ciprofloxacin and cyanocobalamin for ocular drug delivery. |
| Q46786310 | Enhanced reductive dechlorination of tetrachloroethene by nano-sized mackinawite with cyanocobalamin in a highly alkaline condition |
| Q51224233 | Enzymatic decyanation of cyanocobalamin in rat tissues. |
| Q41218204 | Estimation of intrinsic factor and detection of intrinsic factor antibodies using non-radioactive cyanocobalamin and microbiological assay |
| Q50868708 | Evaluation of cyanocobalamin in multivitamin tablets and their Standard Reference Material 3280 by HPLC with visible detection. |
| Q33945080 | Exchange between free and gastric juice-bound cyanocobalamin |
| Q61790435 | Excited electronic states and internal conversion in cyanocobalamin |
| Q80131678 | Factors influencing homocysteineamia in type 2 diabetic patients |
| Q60088395 | Fluoroacetate and Cyanocobalamin Absorption in the Rat |
| Q43875424 | Folacin and cyanocobalamin in relation to natural Trypanosoma evansi infection in buffaloes |
| Q39903764 | Folate status of Ghanaian populations in London and Accra |
| Q24647967 | Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study |
| Q37547491 | Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency. |
| Q46780794 | High-performance liquid chromatography method for the simultaneous determination of thiamine hydrochloride, pyridoxine hydrochloride and cyanocobalamin in pharmaceutical formulations using coulometric electrochemical and ultraviolet detection |
| Q32067756 | Homocysteine, fibrinogen, and lipoprotein(a) levels are simultaneously reduced in patients with chronic renal failure treated with folic acid, pyridoxine, and cyanocobalamin |
| Q44412518 | Hydroxocobalamin and cyanocobalamin interference on co-oximetry based hemoglobin measurements |
| Q47246234 | Identification and characterization of epitopes from influenza A virus hemagglutinin that induce broadly cross-reactive antibodies |
| Q41547812 | Identification and characterization of two enzymes involved in the intracellular metabolism of cobalamin. Cyanocobalamin beta-ligand transferase and microsomal cob(III)alamin reductase |
| Q21203049 | Imerslund-Gräsbeck syndrome (selective vitamin B(12) malabsorption with proteinuria) |
| Q24633277 | Imerslund-Gräsbeck syndrome in a 25-month-old Italian girl caused by a homozygous mutation in AMN |
| Q38311735 | In vitro selection of RNA aptamers specific for cyanocobalamin |
| Q53608771 | In vivo application of chitosan to improve bioavailability of cyanocobalamin, a form of vitamin B12, following intraintestinal administration in rats. |
| Q50979380 | In vivo plasma binding capacity for cyanocobalamin. |
| Q43463108 | Incorporation and metabolic conversion of cyanocobalamin by ehrlich ascites carcinoma cells in vitro and in vivo |
| Q48177690 | Increase in circulating holotranscobalamin after oral administration of cyanocobalamin or hydroxocobalamin in healthy adults with low and normal cobalamin status. |
| Q125770759 | Influence of homocysteine and its major genetic and nutritional determinants on bone mineral density. |
| Q28321465 | Influence of methylcobalamin and cyanocobalamin on the neoplastic process in rats |
| Q39219235 | Intrinsic Factor-Mediated Binding of Cyanocobalamin to Cholestyramine |
| Q47267899 | Intrinsic factor-mediated modulation of cyanocobalamin-N-sulfonyl-acridinium-9-carboxamide chemiluminescence. |
| Q58308672 | Investigation of Cyanocobalamin Interferences to an Electrochemical Based Hemoglobin Test System |
| Q58007530 | Investigation of Receptor-Mediated Cyanocobalamin (Vitamin B12) Transport across the Inner Blood–Retinal Barrier Using Fluorescence-Labeled Cyanocobalamin |
| Q31119137 | LOW LEVELS OF SERUM CYANOCOBALAMIN IN A METFORMIN-TREATED PATIENT. CASE REPORT AND COMPARISON WITH LITERATURE DATA. |
| Q47773506 | Liquid chromatographic mass spectrometric (LC/MS/MS) determination of plasma hydroxocobalamin and cyanocobalamin concentrations after hydroxocobalamin antidote treatment for cyanide poisoning |
| Q46147902 | Liver extract-folic acid-cyanocobalamin vs placebo for chronic fatigue syndrome |
| Q52693215 | Measurement of cyanocobalamin in serum by a specific radioimmunoassay. |
| Q46533538 | Megaloblastic anaemia: Response to amples A and B (folic acid, vitamin B12 (cyanocobalamin), niacin and vitamin C)--a case report |
| Q48105975 | Melatonin prevents hypochlorous acid-mediated cyanocobalamin destruction and cyanogen chloride generation |
| Q39156119 | Metabolic Fate of Cyanocobalamin Taken up by Spirometra mansonoides Spargana |
| Q44414813 | Metabolism of Cyanocobalamin by L-1210 Leukemic Lymphoblasts |
| Q58919546 | Molecular Docking Study on the Interaction of Riboflavin (VitaminB2) and Cyanocobalamin (VitaminB12) Coenzymes |
| Q50465287 | Mutagenic activity of pyrolysates of cyanocobalamin and some other water-soluble vitamins in the model system with the Salmonella/mammalian microsomes. |
| Q46796508 | New studies on intervitamin correlations. VI. Correlative relationship between L-ascorbic acid and five vitamin factors of the B complex in guinea pigs (folic and pantothenic acids, choline, pyridoxine, cyanocobalamin) |
| Q34167370 | Occurrence and characterization of cyanocobalamin reductase (NADPH; CN-eliminating) involved in decyanation of cyanocobalamin in Euglena gracilis |
| Q37729901 | Oral Cyanocobalamin is Effective in the Treatment of Vitamin B12 Deficiency in Crohn's Disease. |
| Q34557880 | Oral cyanocobalamin supplementation in older people with vitamin B12 deficiency: a dose-finding trial |
| Q59209692 | Pharmacokinetics of hydroxy-, adenosyl-, and cyanocobalamins in the case of oral administration to rats |
| Q34196945 | Pharmacokinetics of oral cyanocobalamin formulated with sodium N-[8-(2-hydroxybenzoyl)amino]caprylate (SNAC): an open-label, randomized, single-dose, parallel-group study in healthy male subjects |
| Q52433599 | Photolysis of cyanocobalamin in aqueous solution. |
| Q45205930 | Plasma absorption of cyanocobalamin Co 57. Diagnostic value in vitamin B12 malabsorption states |
| Q79002537 | Plasma disappearance rate and tissue distribution of radioactive cobalt labelled cyanocobalamin injected into various animals |
| Q46312091 | Potentiation of the action of several choline compounds on isolated guinea pig ileum strips by cyanocobalamin, folic acid, riboflavin and neostigmine. |
| Q41615712 | Preliminary characterization of crystals of an in vitro evolved cyanocobalamin (vitamin B12) binding RNA. |
| Q62979636 | Preparation and biodistribution in mice of 99mTc-DTPA-b-cyanocobalamin |
| Q42184445 | Preparation and characterization of cyanocobalamin (vit B12) microemulsion properties and structure for topical and transdermal application |
| Q84064200 | Primary hypogammaglobulinemia associated to pernicious anemia |
| Q45364238 | Production and characterization of cyanocobalamin-enriched lettuce (Lactuca sativa L.) grown using hydroponics. |
| Q47932899 | Psychosis and low cyanocobalamin in a patient abusing nitrous oxide and cannabis. |
| Q41725621 | Purification of human transcobalamin II-cyanocobalamin by affinity chromatography using thermolabile immobilization of cyanocobalamin |
| Q40247805 | REQUIREMENT OF SPHAEROTILUS FOR CYANOCOBALAMIN |
| Q50862257 | Randomized clinical field trial on the effects of butaphosphan-cyanocobalamin and propylene glycol on ketosis resolution and milk production. |
| Q62564766 | Rapid zero-order and second-derivative UV spectrophotometric determination of cyanocobalamin in pharmaceutical formulations containing dextran and preservatives |
| Q42277553 | Relation of blood cyanide to plasma cyanocobalamin concentration after a fixed dose of hydroxocobalamin in cyanide poisoning |
| Q44284487 | Research on the possible protective action of ascorbic acid, thiamine and cyanocobalamin on testicular damage in alloxan diabetes in the rat |
| Q44858732 | Response of Metabolic Encephalopathy to Treatment with Cyanocobalamin |
| Q54515076 | Response of dietary vitamin-B12 deficiency to physiological oral doses of cyanocobalamin. |
| Q53719908 | Retention of cyanocobalamin, hydroxocobalamin, and coenzyme B12 after parenteral administration. |
| Q47156985 | Scientific Opinion on safety and efficacy of vitamin B12(cyanocobalamin) produced byEnsifer adhaerenswhen used as a feed additive for all animal species based on a dossier submitted by Lohamnn Animal Health |
| Q28365355 | Sensitivity to cyanocobalamin and hydroxocobalamin |
| Q52123425 | Serum folate and cyanocobalamin in alcoholics |
| Q30631708 | Similarities and differences between cobalamins and cobaloximes. Accurate structural determination of methylcobalamin and of LiCl- and KCl-containing cyanocobalamins by synchrotron radiation. |
| Q41772168 | Some observations on the measurement of binding of cyanocobalamin by intrinsic factor preparations |
| Q45952222 | Some observations on the possible nutritional significance of vitamin B12-and folate-binding proteins in milk. Absorption of [58Co] cyanocobalamin by suckling piglets |
| Q42977681 | Some properties of the cyanocobalamin-protein complex from sow's milk, and the mode of linkage of cyanocobalamin with protein |
| Q42172042 | Spectral study of photolysis of aqueous cyanocobalamin solutions in presence of vitamins B and C. |
| Q43839719 | Spray-dried powders as nasal absorption enhancers of cyanocobalamin |
| Q51922326 | Stability of cyanocobalamin in sugar-coated tablets. |
| Q42592713 | Stable isotope fractionation of tetrachloroethene during reductive dechlorination by Sulfurospirillum multivorans and Desulfitobacterium sp. strain PCE-S and abiotic reactions with cyanocobalamin. |
| Q40309842 | Studies on the absorption by guinea pig intestine of cyanocobalamin incubated with intrinsic factor |
| Q47702921 | Subacute combined degeneration of the spinal cord in a patient abusing nitrous oxide and self-medicating with cyanocobalamin |
| Q58237524 | Surface enhanced resonance Raman scattering from cyanocobalamin and 5′-deoxyadenosylcobalamin |
| Q33144518 | Syncope following intramuscular injection of hydroxocobalamin in a paraplegic patient: indication for oral administration of cyanocobalamin in spinal cord injury patients |
| Q46006688 | Synergistic antiallodynic interaction between gabapentin or carbamazepine and either benfotiamine or cyanocobalamin in neuropathic rats. |
| Q41293739 | THE URINARY EXCRETION AND TISSUE RETENTION OF CYANOCOBALAMIN BY SUBJECTS GIVEN REPEATED PARENTERAL DOSES. |
| Q58273569 | The Simple Electrochemical Preparation of Vitamin B12a(Aquocobalamin) from Vitamin B12(Cyanocobalamin) |
| Q38975234 | The absorption of folic acid and labelled cyanocobalamin in intestinal malabsorption, with observations on the faecal excretion of fat and nitrogen and the absorption of glucose and xylose |
| Q43155553 | The effect of injectable butaphosphan and cyanocobalamin on postpartum serum beta-hydroxybutyrate, calcium, and phosphorus concentrations in dairy cattle |
| Q51684097 | The forms of vitamin B 12 in the ileal enterocyte of the guinea-pig during fasting and absorption of cyanocobalamin |
| Q41579820 | The mechanism of diarrhoea resulting from pelvic and abdominal radiotherapy; a prospective study using selenium-75 labelled conjugated bile acid and cobalt-58 labelled cyanocobalamin |
| Q42135514 | The occurrence of a cyanocobalamin-binding protein in milk and the isolation of a cyanocobalamin-protein complex from sow's milk |
| Q44511082 | The phagocytic activity of the reticuloendothelial system for colloidal carbon in rats undergoing a treatment with vitamin B complex, with cyanocobalamin, with hydroxycobalamin and with cobamamide |
| Q37205406 | The reaction of HOCl and cyanocobalamin: corrin destruction and the liberation of cyanogen chloride. |
| Q46804779 | The resolution of multiple cyanocobalamin-binding components in serum |
| Q58842934 | The role of benznidazole with cyanocobalamin and ascorbic acid in treating the chronic phase of Chagas disease |
| Q44827524 | Therapeutic misuse of cyanocobalamin |
| Q54058737 | Therapy of neuropathies with a vitamin B combination. Symptomatic treatment of painful diseases of the peripheral nervous system with a combination preparation of thiamine, pyridoxine and cyanocobalamin |
| Q39370239 | Thiamine, pyridoxine, cyanocobalamin and their combination inhibit thermal, but not mechanical hyperalgesia in rats with primary sensory neuron injury |
| Q43571948 | TonB interacts with BtuF, the Escherichia coli periplasmic binding protein for cyanocobalamin |
| Q45245975 | Transport of therapeutic cyanocobalamin in the congenital deficiency of transcobalamin II (TC II) |
| Q37171004 | Type I immediate hypersensitivity reaction to cyanocobalamin but not hydroxycobalamin |
| Q37306770 | Update on oral cyanocobalamin (vitamin B12) treatment in elderly patients |
| Q54738842 | Uptake of cyanocobalamin by Escherichia coli B: Some characteristics and evidence for a binding protein |
| Q34091797 | Vegan diet, subnormal vitamin B-12 status and cardiovascular health |
| Q39841401 | Vitamin B 12-(cyanocobalamin)-allergy |
| Q43798403 | Vitamin B 12-binding glycoproteins. IV. Co57-cyanocobalamin binding capacity of urine in various blood diseases and multiple sclerosis7 9 |
| Q43100140 | Vitamin B(12) deficiency is linked with long-term use of proton pump inhibitors in institutionalized older adults: could a cyanocobalamin nasal spray be beneficial? |
| Q52577343 | Vitamin B12 (cyanocobalamin) in Infant Formula Adult/Pediatric Nutritional Formula by Liquid Chromatography with Ultraviolet Detection: Collaborative Study, Final Action 2014.02. |
| Q53791792 | Vitamin B12 antagonism by monocarboxylic acids and anilides of cyanocobalamin. |
| Q125770655 | Vitamin B12 levels in type 2 diabetic patients on Metformin compared to those never on Metformin: a cross sectional study in Tunisia. |
| Q39484908 | Why has cyanocobalamin not been withdrawn? |
| Q53761590 | [Use of the combination of adrenal cortex extract, pyridoxal-5-phosphate, cyanocobalamin and ascorbic acid in the treatment of hypocorticism in pregnancy] |
| Q187706 | vitamin B12 | different from | P1889 |
| Category:Cyanocobalamin | wikimedia | |
| Arabic (ar / Q13955) | سيانوكوبالامين | wikipedia |
| azb | سیانوکبالامین | wikipedia |
| Catalan (ca / Q7026) | Cianocobalamina | wikipedia |
| cy | Cyanocobalamin | wikipedia |
| Cyanocobalamin | wikipedia | |
| Esperanto (eo / Q143) | Cianokobalamino | wikipedia |
| Cianocobalamina | wikipedia | |
| Persian (fa / Q9168) | سیانوکبالامین | wikipedia |
| Syanokobalamiini | wikipedia | |
| Cyanocobalamine | wikipedia | |
| ga | Cianacóbalaimín | wikipedia |
| gl | Cianocobalamina | wikipedia |
| ציאנוקובלמין | wikipedia | |
| シアノコバラミン | wikipedia | |
| Цианкобаламин | wikipedia | |
| ky | Цианкобаламин | wikipedia |
| ml | സൈനാക്കോബാലമൈൻ | wikipedia |
| Cyanocobalamine | wikipedia | |
| or | ସ୍ୟାନୋକୋବାଲାମିନ | wikipedia |
| Cyjanokobalamina | wikipedia | |
| Cianocobalamină | wikipedia | |
| Serbo-Croatian (sh / Q9301) | Cijanokobalamin | wikipedia |
| Cijanokobalamin | wikipedia | |
| Cyanokobalamin | wikipedia | |
| Ціанокобаламін | wikipedia | |
| Cyanocobalamin | wikipedia |
Search more.